209 related articles for article (PubMed ID: 36008461)
41. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts.
Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S
J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529
[TBL] [Abstract][Full Text] [Related]
42. Differential Interactions between Human ACE2 and Spike RBD of SARS-CoV-2 Variants of Concern.
Kim S; Liu Y; Lei Z; Dicker J; Cao Y; Zhang XF; Im W
J Chem Theory Comput; 2021 Dec; 17(12):7972-7979. PubMed ID: 34856802
[TBL] [Abstract][Full Text] [Related]
43. Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.
Liu Y; Hu G; Wang Y; Ren W; Zhao X; Ji F; Zhu Y; Feng F; Gong M; Ju X; Zhu Y; Cai X; Lan J; Guo J; Xie M; Dong L; Zhu Z; Na J; Wu J; Lan X; Xie Y; Wang X; Yuan Z; Zhang R; Ding Q
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33658332
[TBL] [Abstract][Full Text] [Related]
44. Computational optimization of the SARS-CoV-2 receptor-binding-motif affinity for human ACE2.
Polydorides S; Archontis G
Biophys J; 2021 Jul; 120(14):2859-2871. PubMed ID: 33984310
[TBL] [Abstract][Full Text] [Related]
45. Structural basis for mouse receptor recognition by SARS-CoV-2 omicron variant.
Zhang W; Shi K; Geng Q; Ye G; Aihara H; Li F
Proc Natl Acad Sci U S A; 2022 Nov; 119(44):e2206509119. PubMed ID: 36256797
[TBL] [Abstract][Full Text] [Related]
46. Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals.
Hayashi T; Abiko K; Mandai M; Yaegashi N; Konishi I
Vet Q; 2020 Dec; 40(1):243-249. PubMed ID: 32921279
[TBL] [Abstract][Full Text] [Related]
47.
Tiwari V
Biol Open; 2020 Oct; 9(10):. PubMed ID: 32878881
[TBL] [Abstract][Full Text] [Related]
48. Static all-atom energetic mappings of the SARS-Cov-2 spike protein and dynamic stability analysis of "Up" versus "Down" protomer states.
Peters MH; Bastidas O; Kokron DS; Henze CE
PLoS One; 2020; 15(11):e0241168. PubMed ID: 33170884
[TBL] [Abstract][Full Text] [Related]
49. Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor.
Andrade SA; Batalha-Carvalho JV; Curi R; Wen FH; Covas DT; Chudzinski-Tavassi AM; Moro AM
Front Immunol; 2022; 13():871874. PubMed ID: 35898497
[TBL] [Abstract][Full Text] [Related]
50. Effect of the Graphene Nanosheet on Functions of the Spike Protein in Open and Closed States: Comparison between SARS-CoV-2 Wild Type and the Omicron Variant.
Yan ZS; Li XL; Ma YQ; Ding HM
Langmuir; 2022 Nov; 38(45):13972-13982. PubMed ID: 36318181
[TBL] [Abstract][Full Text] [Related]
51. DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach.
Silwal AP; Thennakoon SKS; Arya SP; Postema RM; Jahan R; Phuoc CMT; Tan X
Theranostics; 2022; 12(12):5522-5536. PubMed ID: 35910791
[No Abstract] [Full Text] [Related]
52. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2.
Verkhivker G
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276
[TBL] [Abstract][Full Text] [Related]
53. Insights into the structural peculiarities of the N-terminal and receptor binding domains of the spike protein from the SARS-CoV-2 Omicron variant.
Bayani F; Safaei Hashkavaei N; Uversky VN; Mozaffari-Jovin S; Sefidbakht Y
Comput Biol Med; 2022 Aug; 147():105735. PubMed ID: 35767919
[TBL] [Abstract][Full Text] [Related]
54. Molecular and computational analysis of spike protein of newly emerged omicron variant in comparison to the delta variant of SARS-CoV-2 in Iraq.
Rashid PMA; Salih GF
Mol Biol Rep; 2022 Aug; 49(8):7437-7445. PubMed ID: 35698014
[TBL] [Abstract][Full Text] [Related]
55. Evolutionary trajectory of receptor binding specificity and promiscuity of the spike protein of SARS-CoV-2.
Planchais C; Reyes-Ruiz A; Lacombe R; Zarantonello A; Lecerf M; Revel M; Roumenina LT; Atanasov BP; Mouquet H; Dimitrov JD
Protein Sci; 2022 Nov; 31(11):e4447. PubMed ID: 36305765
[TBL] [Abstract][Full Text] [Related]
56. An in-silico study of the mutation-associated effects on the spike protein of SARS-CoV-2, Omicron variant.
Shishir TA; Jannat T; Naser IB
PLoS One; 2022; 17(4):e0266844. PubMed ID: 35446879
[TBL] [Abstract][Full Text] [Related]
57. Interaction of the spike protein RBD from SARS-CoV-2 with ACE2: Similarity with SARS-CoV, hot-spot analysis and effect of the receptor polymorphism.
Othman H; Bouslama Z; Brandenburg JT; da Rocha J; Hamdi Y; Ghedira K; Srairi-Abid N; Hazelhurst S
Biochem Biophys Res Commun; 2020 Jun; 527(3):702-708. PubMed ID: 32410735
[TBL] [Abstract][Full Text] [Related]
58. Recombination and lineage-specific mutations linked to the emergence of SARS-CoV-2.
Patiño-Galindo JÁ; Filip I; Chowdhury R; Maranas CD; Sorger PK; AlQuraishi M; Rabadan R
Genome Med; 2021 Aug; 13(1):124. PubMed ID: 34362430
[TBL] [Abstract][Full Text] [Related]
59. A Pathway Model to Understand the Evolution of Spike Protein Binding to ACE2 in SARS-CoV-2 Variants.
Pipitò L; Reynolds CA; Mobarec JC; Vickery O; Deganutti G
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358957
[TBL] [Abstract][Full Text] [Related]
60. A natural food preservative peptide nisin can interact with the SARS-CoV-2 spike protein receptor human ACE2.
Bhattacharya R; Gupta AM; Mitra S; Mandal S; Biswas SR
Virology; 2021 Jan; 552():107-111. PubMed ID: 33130382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
